KRAS and colorectal cancer: He et al. demonstrated for the first time that genetic inactivation of furin suppresses tumor development, proliferation, and migration in colorectal cancer (CRC) cell lines with KRAS or BRAF mutations but not in cells with wild-type KRAS or BRAF.